Illumina said Drs. Frances Arnold, Robert S. Epstein and Gary S. Guthart notified the Board of their intention to retire as directors on April 2, 2026, effective as of May 21, 2026.

1. 01

   Illumina said Drs. Frances Arnold, Robert S. Epstein and Gary S. Guthart notified the Board of their intention to retire as directors on April 2, 2026, effective as of May 21, 2026.

2. 02

   The company said the retirements of Drs. Arnold, Epstein and Guthart are not the result of any dispute or disagreement with the Company or the Board on any matter relating to the operations, policies or practices of the Company.

3. 03

   Illumina said the Board has nominated David King for election as a director at the Company's 2026 annual meeting of stockholders, and announced this on April 2, 2026 in a press release.

4. 04

   The company said David P. King is the former Executive Chairman and CEO of Laboratory Corporation of America Holdings, and currently serves as a director and chair of both Privia Health and AmSurg Corporation, and as a director of Smith & Nephew.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.